| Authors: |
Salvatore L; Oncologia Medica, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli-IRCCS, Rome, Italy; Oncologia Medica, Università Cattolica del Sacro Cuore, Rome, Italy., Fakih M; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA., Kuboki Y; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan., Hong DS; Department of Investigational Cancer Therapeutics, MD Anderson Cancer Center, University of Texas, Houston, TX., Modest DP; Department of Hematology, Oncology and Cancer Immunology, Charité-Universitätsmedizin Berlin, Berlin, Germany., Taieb J; Department of Gastroenterology and Digestive Oncology, Hôpital Européen Georges-Pompidou, Université Paris-Cité, SIRIC CARPEM, Paris, France., Price TJ; Queen Elizabeth Hospital, University of Adelaide, Adelaide, SA, Australia., Cremolini C; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy., Majer IM; Health Economics and Outcomes Research, Amgen (Europe) GmbH, Rotkreuz, Switzerland. Electronic address: imajer@amgen.com., Rehn M; Global Medical Organization, Amgen Inc., Thousand Oaks, CA., Chan E; Global Development, Amgen Inc., Thousand Oaks, CA., Chen Z; Health Economic and Outcomes Research, Amgen Inc., Tampa, FL., Tran Q; Global Biostatistical Science, Amgen Inc., Thousand Oaks, CA., Pietrantonio F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. |
